DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jung-Whoi | ko |
dc.contributor.author | Ku, Tae-Yun | ko |
dc.contributor.author | Yu, Ha-na | ko |
dc.contributor.author | Chong, Kyu-Ha | ko |
dc.contributor.author | Ryu, Seung-Wook | ko |
dc.contributor.author | Choi, Kyung-Sun | ko |
dc.contributor.author | Choi, Chul-Hee | ko |
dc.date.accessioned | 2013-03-12T07:42:32Z | - |
dc.date.available | 2013-03-12T07:42:32Z | - |
dc.date.created | 2012-06-11 | - |
dc.date.created | 2012-06-11 | - |
dc.date.created | 2012-06-11 | - |
dc.date.created | 2012-06-11 | - |
dc.date.issued | 2012-05 | - |
dc.identifier.citation | CANCER LETTERS, v.318, no.2, pp.221 - 225 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | http://hdl.handle.net/10203/101682 | - |
dc.description.abstract | Blockade of VEGF signaling using RNA interferences, a neutralizing antibody, an antagonizing soluble VEGF receptor, and a receptor tyrosine kinase inhibitor induced anti-tumor effects in human astrocytoma U251-MG and fibrosarcoma HT-1080 in vitro in a dose-dependent manner. Furthermore, blockade of VEGF-A using the doxycycline-inducible VEGF-A RNA interference system showed a significant antitumor effect in a murine HT-1080-xenograft model. Anti-tumor effect through the blockade of VEGF signaling was mediated by FAK and AKT pathway in vitro and in vivo. These results collectively indicate that VEGF-A and its receptors can act as key inducer of tumor growth as well as angiogenesis. (C) 2011 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.title | Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT | - |
dc.type | Article | - |
dc.identifier.wosid | 000302430000013 | - |
dc.identifier.scopusid | 2-s2.0-84858158912 | - |
dc.type.rims | ART | - |
dc.citation.volume | 318 | - |
dc.citation.issue | 2 | - |
dc.citation.beginningpage | 221 | - |
dc.citation.endingpage | 225 | - |
dc.citation.publicationname | CANCER LETTERS | - |
dc.identifier.doi | 10.1016/j.canlet.2011.12.014 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.contributor.localauthor | Ku, Tae-Yun | - |
dc.contributor.localauthor | Choi, Chul-Hee | - |
dc.description.isOpenAccess | N | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | VEGF | - |
dc.subject.keywordAuthor | FAK | - |
dc.subject.keywordAuthor | AKT | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Autocrine signaling | - |
dc.subject.keywordPlus | ANGIOGENESIS | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | DISEASES | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | CELLS | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.